Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Anti-inflammatory Properties of Cannabidiol, a Nonpsychotropic Cannabinoid, in Experimental Allergic Contact Dermatitis.

Petrosino S, Verde R, Vaia M, AllarĂ  M, Iuvone T, Di Marzo V.

J Pharmacol Exp Ther. 2018 Jun;365(3):652-663. doi: 10.1124/jpet.117.244368. Epub 2018 Apr 9.

PMID:
29632236
2.

Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis.

Vaia M, Petrosino S, De Filippis D, Negro L, Guarino A, Carnuccio R, Di Marzo V, Iuvone T.

Eur J Pharmacol. 2016 Nov 15;791:669-674. doi: 10.1016/j.ejphar.2016.10.005. Epub 2016 Oct 5.

PMID:
27720681
3.

Reply.

Iuvone T, Affaitati G, De Filippis D, Lopopolo M, Grassi G, Lapenna D, Negro L, Costantini R, Vaia M, Cipollone F, Ialenti A, Giamberardino MA.

Pain. 2016 Mar;157(3):770-1. doi: 10.1097/j.pain.0000000000000400. No abstract available. Erratum in: Pain. 2016 Apr;157(4):991.

PMID:
26871400
4.

Ultramicronized palmitoylethanolamide reduces viscerovisceral hyperalgesia in a rat model of endometriosis plus ureteral calculosis: role of mast cells.

Iuvone T, Affaitati G, De Filippis D, Lopopolo M, Grassia G, Lapenna D, Negro L, Costantini R, Vaia M, Cipollone F, Ialenti A, Giamberardino MA.

Pain. 2016 Jan;157(1):80-91. doi: 10.1097/j.pain.0000000000000220.

PMID:
25974242
5.

New insights in mast cell modulation by palmitoylethanolamide.

De Filippis D, Negro L, Vaia M, Cinelli MP, Iuvone T.

CNS Neurol Disord Drug Targets. 2013 Feb 1;12(1):78-83. Review.

PMID:
23394523

Supplemental Content

Support Center